Colorectal Cancer Classification Systems

Key points
- The two most common classification systems are the Dukes and TNM (tumor/node/metastasis) systems.
- The TNM system is based on the anatomic extent of the cancer.
- The National Cancer Institute recently convened an expert panel to develop guidelines for colon and rectal surgery.
- The original Dukes system was developed for classification of rectal cancers.
The two most common classification systems are the Dukes and TNM (tumor/node/metastasis) systems. The original Dukes system was developed for classification of rectal cancers. Dukes A describes a rectal tumor that has not penetrated the wall and has no nodal involvement. Dukes B involves a penetrating cancer through the rectal wall but with no nodal involvement. Dukes C indicates lymph node involvement. The Dukes system was modified by Kirklin in 1949, extending the classification to include colon cancers. Turnbull in 1967 added Dukes D to describe metastases to distant organs. The Dukes classification fails to take into account the number of involved nodes and clinical factors, but it is still the single best predictor of survival.
The TNM system is based on the anatomic extent of the cancer. T stands for the extent of the primary tumor, N for the condition of the regional lymph nodes, and M for the presence or absence of distant metastases at the time of diagnosis.
The National Cancer Institute recently convened an expert panel to develop guidelines for colon and rectal surgery. As a result of this meeting, the panel recommended using the TNM system for tumor staging based on a review of the best available evidence.
{embed="cr/stat-menu-colon"}
Gregory L. Brotzman and Russell G. Robertson
{embed="cr/colon-ref"}
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBiomarker identification may lead to new noninvasive test for colorectal cancer detection
The average 5-year survival for colorectal cancer (CRC) is less than 10% if metastasis occurs, but can reach 90% if detected early. A new non-invasive test has been developed that measures methylation of the SDC2 gene…
7 June 2013
NewsSleep duration associated with higher colorectal cancer risk
A new study is the first to report a significant positive association between long sleep duration and the development of colorectal cancer , especially among individuals who are overweight or snore regularly. The…
2 May 2013
NewsSoy-based compound may reduce tumor cell proliferation in colorectal cancer
Research on a soy-based treatment for colorectal cancer, a promising agent in ovarian cancer, and a new drug target for advanced prostate cancer was presented at the American Association for Cancer Research 2013 Annual…


